Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics

International Journal of Toxicology

Volumn 24, Issue SUPPL. 2, 2005, Pages 21-50

  Anderson, F Alan ^a  

^a Cosmetic Ingredient Review ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; CARBON 14; COSMETIC; DEODORANT AGENT; EPOXIDE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCIDAMIDE; POLYACRYLAMIDE; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ACUTE TOXICITY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTOMA; BREAST TUMOR; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMICAL INDUSTRY; CHEMICAL STRUCTURE; CHRONIC TOXICITY; CONTROLLED STUDY; COSMETIC INDUSTRY; CREAM; DOSE RESPONSE; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; EYE IRRITATION; FIBROADENOMA; FOOD AND DRUG ADMINISTRATION; GENOTOXICITY; HEALTH HAZARD; HUMAN; HYDROGEL; INFRARED SPECTROSCOPY; ISOTOPE LABELING; LOTION; MOUSE; MOUTH TUMOR; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PAPILLOMA; POLYMERIZATION; RAT; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SAFETY; SKIN ABSORPTION; SKIN IRRITATION; THYROID FOLLICULAR CARCINOMA; TISSUE DISTRIBUTION;

ACRYLAMIDES; ACRYLIC RESINS; ADMINISTRATION, TOPICAL; ANIMALS; CARCINOGENICITY TESTS; COSMETICS; DROSOPHILA; EYE DISEASES; GROWTH; HUMANS; IRRITANTS; MAMMALS; MUTAGENICITY TESTS; SKIN ABSORPTION; SKIN TESTS; TERATOGENS;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA;

EID: 22344435984     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810590953842     Document Type: Review

References (103)

1. Abernathy, C. O., M. S. Ottley, J. H. Brantner, and P. F. Hayes. 1988. Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res. 195:45-77.
2. Adler, I-D., I. Ingwerson, U. Kliesch, and A. El Tarras. 1988. Clastogenic effects of acrylamide in mouse bone marrow cells. Mutat. Res. 206:379-385.
3. 2
4. 2
5. Arany, J. 1985. Acrylamide monomer Salmonella/microsome test (SMT). NTIS Report OTS-0000440-0.
6. Bergmark, E., C. J. Calleman, F. He, and L. G. Costa. 1993. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol. 120:45-54.
7. Bissett, D. L. 1980. Development of a model of human cervical mucus. Fertil. Steril. 33:211-2.
8. Bull, R. J., M. Robinson, R. D. Laurie, G. D. Stoner, E. Greisiger, J. R. Meier, and J. Stober. 1984a. Carcinogenic effects of acrylamide in Sencar and A/J Mice. Cancer Res. 44:107-111.
9. Bull, R. J., M. Robinson, and J. A. Stober. 1984b. Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett. 24:209-212.
10. Bunting, P. S., and K. J. Laidler. 1973. Some properties of alpha-chymotrypsin and beta-galactosidase supported in polyacrylamide gels. Can. J. Biochem. 51:1598-1603.
11. Calleman, C. J., Y. Wu, F. He, G. Tian, E. Bergmark, S. Zhang, H. Deng, Y. Wang, K. M. Crofton, T. Fennel, and L. G. Costa. 1994. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126:361-371.
12. 14C]acrylamide to macromolecules in SENCAR and BALB/c mice following oral and topical administration. Toxicol. Appl. Pharmacol. 79:307-313.
13. Cervenka, J., et al. 1972. New method for studying the influence of steroids on the vaginal cell of the trigone of the rat. Acta Cytol. 16:386-387.
14. Chapin, R. E., P. A. Fail, J. D. George, R. B. Grizzle, J. J. Heindel, G. J. Harry, B. J. Collins, and J. Teague. 1995. The reproductive and neural toxicities of acrylamide and three analogues in Swiss mice, evaluated using the continuous breeding protocol. Fundam. Appl. Toxicol. 27:9-24.
15. Christofano, E. E., et al. 1969. The toxicology of modified polyacrylamide resin. Toxicol. Appl. Pharmacol. 14:616.
16. Čihák, R., and M. Vontorková. 1988. Cytogenic effects of acrylamide in the bone marrow of mice. Mutat. Res. 209:91-94.
17. COLIPA. 1999. Quantification of cancer risk due to dermal exposure to acrylamide as a result of cosmetic application. Unpublished data submitted by the European Cosmetic Toiletry and Perfumary Association (COLIPA) to the European Commission. 15 pages.
18. 2
19. 2
20. Couvreur, P. et al. 1977. Nanocapsules: A new type of lysosomal carrier. FEBS Lett 84:323-326.
21. Damjanov, I., and M. A. Friedman. 1998. Mesotheliomas of tunica vaginalis testis of Fischer 344 (F344) rats treated with acrylamide: A light and electron microscopy study. In Vivo 12:495-502.
22. Davis, B. K. 1972. Control of diabetes with polyacrylamide implants containing insulin. Experientia 28:348.
23. Davis, B. K., I. Noske, and M. C. Chang. 1972. Reproductive performance of hamsters with polyacrylamide implants containing ethynylestradiol. Acta Endocrinol. (Copenh.) 70:385-395.
24. 2
25. 2
26. 2
27. 2
28. 2
29. Edman, P., and I. Sjoholm. 1981. Prolongation of effect of asparaginase by implantation in polyacrylamide in rats. J. Pharm. Sci. 70:684-685.
30. Ehling, U. H., and A. Neuhäuser-Klaus. 1992. Reevaluation of the induction of specific-locus mutations in spermatogonia of the mouse by acrylamide. Mutat. Res. 283:185-192.
31. Environmental Protection Agency (EPA). 1990. Assessment of health risks from exposure to acrylamide. Washington, DC: U. S. EPA.
32. Epton, R., J. V. McLaren, and T. H. Thomas. 1973. Water-insoluble polyacrylamide-thermolysin conjugates. Biochim. Biophys. Acta 328:418-427.
33. European Commission. 1999. Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning ACRYLAMIDE RESIDUES IN COSMETICS adopted by the plenary session of the SCCNFP of 30 September 1999. http://europa. eu. int/comm/food/fs/sc/sccp/out95_en. html.
34. Food and Drug Administration (FDA). 1989. Cosmetic ingredient concentration and frequency of use data. FDA database. Washington, DC: FDA.
35. FDA. 2002. Cosmetic ingredient product frequency of use data. FDA database. Washington, DC: FDA.
36. FDA. 2003. Acrylamide in food. Information from the FDA web site. http://www.cfsan.fda.gov/dms/acryplan.html and http://www.fda.gov/fdac/ features/2003/103_food. html.
37. 2
38. Friedman, M. A., L. H. Dulak, and M. A. Stedham. 1995. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27:95-105.
39. Fujiki, M., J. Asada, and T. Shimizu. 1985. Studies on analytical method of acrylamide monomer and accumulation into fish. Goverment Reports, Announcements and Index. AD-P004 735, AD-P004 761.
40. Generoso, W. M., G. A. Sega, A. M. Lockhart, L. A. Hughes, K. T. Cain, N. L. A. Cacheiro, and M. D. Shelby. 1996. Dominant lethal mutations, heritable translocations, and unscheduled DNA synthesis induced in male mouse germ cells by glycidamide, a metabolite of acrylamide. Mutat. Res. 371:175-183.
41. Greenberg, K. 2002. Using panels to understand the consumer. Consumer Insight Magazine, http://acnielson.com/pubs/ci/2002/ql/features/panels. htm.
42. Guillot, J. P., et al. 1982. Safety evaluation of gums and thickeners use in cosmetic formulations. Int. J. Cosmet. Sci. 4:53-65.
43. Guillot, J. P., et al. 1983. Anti-irritant potential of cosmetic raw materials and formulations. Int. J. Cosmet. Sci. 5:255-265.
44. Gutierrez-Espeleta, G. A., L. A. Hughes, W. W. Piegorsch, M. D. Shelby, and W. M. Generoso. 1992. Acrylamide: Dermal exposure produces genetic damage in male mouse germ cells. Fundam. Appl. Toxicol. 18:189-192.
45. Hawley, G. G., ed. 1971. The condensed chemical dictionary, 174. New York: Van Nostrand Reinhold.
46. Hendricxx, B. 1985. Mitotic recombination in Saccharomyces cerevisiae DV (MRC). NTIS Report OTS0000440-0.
47. Hills, B. 1985. Industrywide studies report of walkthrough survey of American Cyanamid plant, Westwego, Louisiana, project no. P-84-30. Division of Surveillance, Hazard Evaluations, and Field Studies, NIOSH, HHS. Report no. IWS-145-14. Cincinnati, Ohio: NIOSH.
48. Hollander, L. 1952. Preliminary patch test results in 25 persons. NTIS Report No. OTS-0206055.
49. International Agency for Research on Cancer. 1986. Some chemicals used in plastics and elastomers. World Health Organization, ISBN#92-832-1239-8, vol. 39.
50. Isacoff, H. 1973. Polyacrylamides in cosmetics. Cosmet. Perfum. 88:35-37.
51. Isacoff, H., and T. F. Zeigler. 1978. Water soluble polyacrylamides in cosmetics. Drug. Cosmet. Ind. 123:46-49.
52. Johnson, K. A., S. J. Gorzinski, K. M. Bodner, R. A. Campbell, C. H. Wolf, M. A. Friedman, and R. W. Mast. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85:154-168.
53. Jones, T. L., and J. S. Haskill. 1976. Use of polyacrylamide for cloning of primary tumors. Methods Cell. Biol. 14:195-203.
54. 2
55. Krebs, O., and J. Favor. 1997. Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitosourea. Mutat. Res. 388:239-248.
56. Maichuk, Y. F. 1975. Soluble ophthalmic drug inserts. Lancet 1:173-174.
57. Marchetti, F., X. Lowe, J. Bishop, and A. J. Wyrobek. 1997. Induction of chromosomal aberrations in mouse zygotes by acrylamide treatment of male germ cells and their correlation with dominant lethality and heritable translocations. Environ. Mol. Mutagen. 30:410-417.
58. Marsh, G. M., L. J. Lucas, A. O. Youk, and L. C. Schall. 1999. Mortality patterns among workers exposed to acrylamide: 1994 follow-up. Occup. Environ. Med. 56:181-190.
59. Marty, J.-P., and C.-M. Vincent. 1998. In vitro percutaneous absorption of acrylamide across human skin. Unpublished data submitted by CTFA. 63 pages.
60. McCollister, D. D., C. L. Hake, S. E. Sadek, and V. K. Rowe. 1965. Toxicologic investigations of polyacrylamides. Toxicol. Appl. Pharmacol. 7(5):639-651.
61. Ministry of Health, Labor, and Welfare (MHLW). 2000. Pharmaceutical and Medical Safety Bureau Notification No. 990. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Divison, 2-2, 1-chrome, Kasumigaseki, Chiybda-ku, Tokyo 100-8045, Japan.
62. Molyneux, P. 1984. Water soluble polyacrylamides in cosmetics. Drug Cosmet. Ind. 123:46-49.
63. Mukhtar, H., R. Dixit, and P. K. Seth. 1981. Reduction in glutathione and hepatic glutathione contents, glutathione S-transferase, and aryl hydrocarbon hydrdxylase activities following topical application of acrylamide to mouse. Toxicol. Lett. 9:153-156.
64. Nadler, H. L., and S. J. Updike. 1974. Gel entrapment of enzyme. Strategy for enzyme correction. Enzyme 18:150-160.
65. National Industrial Chemicals Notification and Assessment Scheme (NICNAS), Australia. 2002. Acrylamide. Priority Existing Chemical Assessment Report No. 23. Commonwealth of Australia: Sydney, NSW
66. Ono, Y., and M. A. Stahmann. 1972. A new detection method for penicillin antibodies and hypersensitivity in humans using penicillin coupled to polyacrylamide particles. Immunochemistry 9:1087-1093.
67. Pepe, R. C., J. A. Wenninger, and G. N. McEwen, Jr. eds. 2002. International cosmetic ingredient dictionary and handbook. 9th ed., Vol. 2. Washington, DC: CTFA.
68. Pharmakon Research International, Inc. 1982a. Ames Salmonella/microsome plate test. PH 301D-AC-004-82. Acrylamide monomer and acrylonitrile. NTIS Report No. OTS0206055.
69. Pharmakon Research International, Inc. 1982b. CHO/HGPRT mammalian cell forward gene mutation assay with and without metabolic activation. PH 314-AC-001-82. Acrylamide. NTIS Report No. OTS0206055.
70. Pharmakon Research International, Inc. 1982c. Rat hepatocyte primary culture/DNA repair test. PH 311-AC-001-82. Acrylamide. NTIS Report No. OTS0206055.
71. Ramsey, J. C., J. D. Young, and S. J. Gorzinski. 1984. Acrylamide: Toxicodynamics in rats. Unpublished data submitted by CTFA. 14 pages.
72. Ratner, B. D., and A. S. Hoffman. 1975-76. Synthetic hydrogels for biomedical applications. ACS. Symp. Ser. 31:1-36.
73. Russell, L. B., P. R. Hunsicker, N. L. A. Cacheiro, and W. M. Generoso. 1991. Induction of specific-locus mutations in male germ cells of the mouse by acrylamide monomer. Mutat. Res. 262:101-107.
74. Russo, A., G. Gabbani, and B. Simoncini. 1994. Weak genotoxicity of acrylamide on premeiotic and somatic cells of the mouse. Mutat. Res. 309:263-272.
75. Saettone, M. F., et al. 1986. Semi-solid ophthalmic vehicles. III. An evaluation of four organic hydrogels containing pilocarpine. Int. J. Pharm. 31:261-270.
76. Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP). 1999. Opinion on acrylamide residues in cosmetics adopted by the plenary session of the SCCNFP of 30, September 1999. http://europa.eu.int/comm/food/fs/sc/sccp/out95.en.html
77. Scientific Committee on Food (SCF). Opinion of the SCF on new findings regarding the presence of acrylamide in food expressed on 3 July, 2002. http://europa.eu.int/comm/food/fs/sc/scf/out131_en.html
78. Scientific Committee on Toxicity, Exotoxicity, and the Environment (CSTEE). Opinion on the results of the risk assessment of: Acrylamide. Opinion expressed at the 22nd CSTEE plenary meeting, 6/7 March, 2001. http://europa.eu.int/comm/food/fs/sc/sct/outcome_en.html
79. Sega, G. A., and E. E. Generoso. 1990. Measurement of DNA breakage in specific germ-cell stages of male mice exposed to acrylamide, using an alkaline-elution procedure. Mutat. Res. 242:79-87.
80. Sega, G. A., E. E. Generoso, and P. A. Brimer. 1990. Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA. Environ. Mol. Mutagen. 16:137-142.
81. Sega, G. A., R. P. Valdivia Alcota, C. P. Tancongo, and P. A. Brimer. 1989. Acrylamide:binding to the DNA and protamine of spermiogenic stages in the mouse and its relationship to genetic damage. Mutat. Res. 216:221-230.
82. Shelby, M. D., K. T. Cain, C. V. Comett, and W. M. Generoso. 1987. Acrylamide: Induction of heritable translocations in male mice. Environ. Mutagen. 9:363-368.
83. 2
84. 2
85. Sickles, D., D. A. Weller, and M. A. Friedman. 1995. Acrylamide arrests mitosis and prevents chromosome migration in the absence of changes in spindle microtubules. J. Toxicol. Environ. Health 44:73-86.
86. Silvestro, E., and M. Cracker. 1981. Toxicity of chemical compounds used for enhanced oil recovery. Final Report. Government Reports, Announcements, and Index 8:2(5-6), 3(1-4).
87. Smith, E. A., and F. W. Oehme. 1991. Acrylamide and polyacrylamide: A review of production, use, environmental fate, and neurotoxicity. Rev. Environ. Health 9:215-228.
88. 2
89. 2
90. 2
91. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5:81-89.
92. 2
93. Suzuki, J. K. Hukushima, and S. Suzuki. 1978. Effect of ozone treatment upon biodegradability of water-soluble polymers. Environ. Sci. Techol. 12:1180-1183.
94. Taylor, D. E., and J. E. Penhallow. 1986. Comparative biotolerance of polyacrylamide-agarose gel, silicone rubber and microporous PTFE as soft tissue implants. Biomaterials 7:277-82.
95. Tripathy, N. K., K. K. Patnaik, and Md. J. Nabi. 1991. Acrylamide is genotoxic to the somatic and germ cells of Drosophila melanogaster. Mutat. Res. 259:21-27.
96. Tsuda, H., C. S. Shimizu, M. K. Taketomi, M. M. Hasegawa, A. Hamada, K. M. Kawata, and N Inui. 1993. Acrylamide: Induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations. Mutagenesis 8:23-29.
97. Union Carbide. 1987. Combined two-generation reproduction study and dominant lethal assay in Fischer 344 rats administered acrylamide in the drinking water. NTIS Report No. OTS0536439.
98. Updike, S. 1977. Strategy for enzyme therapy. Immobilization in hypoallergenic gel versus entrapment in red blood cells. Biomed Appl. Immobilized Enzyme Proteins 1:245-255.
99. Valencia, R. 1984. Drosophila sex-linked recessive assay of acrylamide. NTIS Report No. OTS-0206897.
100. West, R. 1959. Investigation of the fate of orally administered acrylamide in small animals using carbon-14 tagged material. NTIS Report OTS-0206055.
101. Wielopolski, L., et al. 1985. Polyacrylamide-based phantoms is tissue substitute in experimental radiation physics. Medical Physics 12:788-792.
102. World Health Organization (WHO). 1985. Acrylamide. Environm. Health Criteria 49:1-121.
103. WHO. 1996. Guidelines for drinking water quality. Vol 2. Health criteria and other supporting information, 2nd ed. Geneva: WHO.